Results 131 to 140 of about 11,328,563 (174)

FDA Approval of Donanemab-azbt: A New Dawn in Alzheimer's Disease Treatment. [PDF]

Health Sci Rep
Riaz R, Fatima M, Ramzan S, Rathi D, Fatima F, Farooq M, Shaukat A, Khaliq N, Akilimali A.   +8 more
europepmc   +1 more source

Real-world safety and implementation challenges of lecanemab therapy for Alzheimer's disease in South Korea: a single-center experience. [PDF]

Alzheimers Res Ther
Jang H, Kim JW, Hwang JW, Jeong DW, Ka J, Kang DM, Suh CH, Choi Y, Oh M, Kim JS, Lim JS, Lee JH.   +11 more
europepmc   +1 more source

Correction: Higher phosphorylated tau levels predict cognitive decline and amyloid-related imaging abnormalities during lecanemab treatment: clinical practice data. [PDF]

Alzheimers Res Ther
Noguchi-Shinohara M, Yoshinobu T, Ozaki T, Muramatsu D, Shima A, Sakashita Y, Tada Y, Yamaguchi H, Komatsu J, Ikeda T, Ono K.   +10 more
europepmc   +1 more source

Investigating the Inflammatory Infiltrate in Cerebral Amyloid Angiopathy-related inflammation (CAA-ri): A Model for Amyloid-Related Imaging Abnormalities (ARIA)

Cerebral Circulation - Cognition and Behavior
Bethany Cro Jessica Luxford, Emma J Norton, J Robin Highley, Kathreena M Kurian, Zane Jaunmuktane, Mark Fabian, Mark Walker, James AR Nicholl, Delphine Boche   +8 more
openaire   +1 more source

Further data to address the Alzheimer's coverage with evidence development questions. [PDF]

Alzheimers Dement
Boustani M, Klein EG, Zimmer JA, Wang H, Engle SE, Phipps A, Japha M, Schilling T, Hartry A, Alzheimer's Disease Neuroimaging Initiative.   +9 more
europepmc   +1 more source

Differences in anti-amyloid therapy eligibility assessment based on use of the SWI versus GRE sequence. [PDF]

Alzheimers Dement (Amst)
Bermudez C, Pillai JJ, Burkett BJ, McDonald JS, Johnson DR, Wiste HJ, Weigand SD, Jack CR, Vemuri P, Petersen RC, Graff-Radford J, Ramanan VK, Cogswell PM.   +12 more
europepmc   +1 more source

Updated Italian intersocietal recommendations for the appropriate use of anti-amyloid monoclonal antibodies in Alzheimer's disease. [PDF]

J Prev Alzheimers Dis
Benussi A, Agosta F, Agnello L, Alfano AR, Altini M, Antico A, Basilico S, Bellelli G, Bonanni L, Bottini G, Bozzali M, Brignoli O, Bruno G, Cagnin A, Calloni SF, Cappa SF, Caraci F, Cecchin D, Ciaccio M, Cocozza S, Cosottini M, De Leo D, Falini A, Gaetani L, Gandolfo N, Gotta F, Lodi R, Logroscino G, Marcello E, Marra C, Marrocco W, Morbelli S, Mecocci P, Mossello E, Palleschi L, Palumbo P, Pantoni L, Parnetti L, Roccatagliata L, Sorbi S, Spadin P, Splendiani A, Tessitore A, Ungar A, Zappalà G, Padovani A.   +45 more
europepmc   +1 more source

A Severe Symptomatic Case of Amyloid-Related Imaging Abnormalities After Donanemab Infusion. [PDF]

Cureus
Harikumar N, Gupta M, Al Janabi T, Mand KK.   +3 more
europepmc   +1 more source